💥UPSC 2027,2028 Mentorship (June Batch) + Access XFactor Notes & Microthemes PDF
Talk to mentor

Civilsdaily

Login

Archives: News

  • Foreign Policy Watch: India-Middle East

    Signals from the India-Arab Delhi Decleration

    3 February 2026 | Explained | International Relations
    Mains Paper 2: Bilateral, Regional and Global Groupings and agreements involving India

    Why in the news?

    India and Arab League adopted ‘New Delhi Declaration‘ following the Second India-Arab Foreign Ministers’ Meeting. It is significant because it comes after an eight-year gap in India-Arab League engagement and amid escalating regional turmoil in West Asia. It clarifies India’s positions on Palestine, Yemen, Sudan, and maritime security while remaining silent on sensitive fault lines such as Iran-US tensions. 

    What Was the Context of the Delhi Declaration?

    1. Eight-year diplomatic gap: Reflects revival of India-Arab League engagement after the last interaction in 2018.
    2. Regional instability: Occurs amid Gaza conflict, Red Sea disruptions, Yemen crisis, and Sudan civil war.
    3. US policy flux: Coincides with uncertainty over US approaches to Israel-Palestine and regional security.
    4. Multipolar alignment: Signals India’s attempt to engage Arab states without aligning against any major power.

    How Did the Declaration Address the Israel-Palestine Question?

    1. Explicit condemnation of violence: Condemns atrocities against civilians, aligning with Arab League language.
    2. Two-State solution reaffirmation: Supports an independent Palestinian state based on pre-1967 borders.
    3. Normative consistency: Reinforces India’s long-standing position while maintaining relations with Israel.
    4. Strategic restraint: Avoids direct criticism of Israel or endorsement of military escalation.

    What Does the Declaration Signal on Regional Conflicts?

    1. Yemen conflict: Supports unity and territorial integrity, reflecting concern over instability near key sea lanes.
    2. Sudan crisis: Notes humanitarian catastrophe caused by Rapid Support Forces and internal fragmentation.
    3. Syria normalization: Welcomes reintegration of Syria into Arab League diplomacy post-isolation.
    4. Selective engagement: Avoids naming non-Arab actors, maintaining diplomatic neutrality.

    Why Is the Silence on Certain Issues Important?

    1. Iran-US tensions: No reference, despite escalating hostilities and regional polarization.
    2. Red Sea militarization: Avoids explicit reference to US-led security initiatives.
    3. Abraham Accords: No endorsement or critique, maintaining India’s independent stance.
    4. Strategic ambiguity: Preserves India’s ability to engage all sides without diplomatic costs.

    What Are the Economic and Strategic Stakes for India?

    1. Energy security: Arab states remain central to India’s crude oil and LNG imports.
    2. Trade dependency: West Asia is a key market for Indian exports and remittances.
    3. Diaspora presence: Large Indian workforce heightens stakes in regional stability.
    4. Connectivity routes: Red Sea disruptions directly affect India’s maritime trade.

    How Does the Declaration Reflect India’s Diplomatic Strategy?

    1. Strategic autonomy: Avoids alignment with US or regional blocs.
    2. Issue-based convergence: Supports Arab consensus where interests overlap.
    3. Normative positioning: Upholds sovereignty, territorial integrity, and civilian protection.
    4. Balancing posture: Manages ties with Israel, Arab states, Iran, and the US simultaneously.

    Conclusion

    The India-Arab League Delhi Declaration reflects a careful diplomatic calibration rather than a declaratory shift. By selectively aligning with Arab positions, avoiding contentious fault lines, and emphasizing stability and sovereignty, India signals its aspiration to be a credible, non-aligned stakeholder in West Asia. The document underscores India’s preference for strategic ambiguity, issue-based cooperation, and diplomatic balance in an increasingly fragmented regional order.

    Arab League

    1. The Arab League, officially the League of Arab States, is a regional organization of 22 member nations in the Middle East and North Africa. 
    2. It was established on March 22, 1945, in Cairo.
    3. Its primary mission is to strengthen ties among member states, coordinate political activities, and safeguard their independence and sovereignty.
    4. Headquarters: Cairo, Egypt (briefly moved to Tunis from 1979-1989 after Egypt’s suspension).
    5. Members: The League grew from seven founding members to its current 22: 
      1. Founders: Egypt, Iraq, Jordan, Lebanon, Saudi Arabia, Syria, Yemen.
      2. Other Members: Algeria, Bahrain, Comoros, Djibouti, Kuwait, Libya, Mauritania, Morocco, Oman, Palestine, Qatar, Somalia, Sudan, Tunisia, United Arab Emirates.
      3. Observers: Includes nations like Brazil, Eritrea, India, and Venezuela

    PYQ Relevance

    [UPSC 2017] The question of India’s Energy Security constitutes the most important part of India’s economic progress. Analyze India’s energy policy cooperation with West Asian countries.

    Linkage: It is a core GS-II topic covering India’s foreign policy, energy security, and strategic relations with West Asia. The India-Arab Delhi Declaration reinforces energy interdependence and regional stability as prerequisites for securing India’s hydrocarbon supplies and economic growth.

    Get an IAS/IPS ranker as your 1: 1 personal mentor

  • Pharma Sector – Drug Pricing, NPPA, FDC, Generics, etc.

    Rs10,000-crore dosage for biobharma

    3 February 2026 | Explained | Economics
    Mains Paper 3: Indian Economy

    Why in the News

    India is the 3rd largest pharmaceutical producer by volume and 14th by value, yet remains heavily dependent on imports for high-value biologic medicines. Biologics dominate modern treatment for cancer, diabetes, rheumatoid arthritis, and infectious diseases, while biosimilars offer cost-effective alternatives. The Union Budget 2026-27 announced Biopharma SHAKTI, a ₹10,000-crore initiative over five years to strengthen domestic production of biologics and biosimilars. This is the first dedicated national framework for biopharma, contrasting with earlier schemes that treated biologics as sub-components of biotechnology or pharma policy. The announcement is significant as biologics now account for a major share of therapies for cancer, diabetes, autoimmune disorders, and vaccines, while India aims to capture 5% of the global biopharmaceutical market.

    What Is Biopharma and Why Does It Matter?

    1. Biopharma, or biopharmaceuticals, refers to the part of the pharmaceutical industry that focuses on developing and manufacturing medicines using living biological systems, rather than relying solely on chemical synthesis.
    2. Biopharma medicines are produced by working with cells, microorganisms or other biological materials. These may include human or animal cells, bacteria, fungi or similar biological platforms that are used to grow or produce therapeutic substances
    3. Biopharmaceuticals: Medicines produced using living biological systems such as human or animal cells, bacteria, fungi, or microbes rather than chemical synthesis.
    4. Product categories: Include vaccines, therapeutic proteins, monoclonal antibodies, gene and cell therapies, modern insulin, and recombinant protein drugs.
    5. Biosimilars: Near-identical versions of approved biologic medicines that offer affordable alternatives once patent protection expires
    6. Biologics: They are complex medicines derived from living cells, while biosimilars are highly similar, equally safe, and effective, lower-cost alternatives to already approved biologics.
      1. While biologics are the original, brand-name, and often more expensive drugs, biosimilars are approved after the original patent expires, offering similar, high-quality, and, on average, 15%-35% cheaper, therapeutic options for diseases like cancer and arthritis.

    What is Biopharma SHAKTI?

    1. It is a dedicated national initiative with an outlay of Rs. 10,000 crores over five years, aimed at strengthening India’s end-to-end ecosystem for biologics and biosimilars.
    2. Aim: It is designed to:
      1. support domestic development and manufacturing of high-value biopharmaceutical products and medicines
      2. reduce import dependence
      3. enhance India’s competitiveness in global biologics supply chains.
    3. Institutional expansion: Expansion and strengthening of the Biopharma-focused network through the establishment of three new National Institutes of Pharmaceutical Education and Research (NIPERs) and the upgradation of seven existing NIPERs
    4. Creation of a large-scale clinical research ecosystem, with a proposal to develop over 1,000 accredited clinical trial sites across the country.

    How Is Clinical Research Capacity Being Strengthened?

    1. Trial infrastructure: Proposes 1,000+ accredited clinical trial sites nationwide.
    2. Advanced trials: Enhances capacity for complex biologics and biosimilar trials.
    3. Global credibility: Positions India as a preferred destination for ethical and efficient clinical research.

    What Regulatory Reforms Are Emphasised?

    1. Institutional strengthening: Enhances capacity of the Central Drugs Standard Control Organisation (CDSCO).
    2. Technical expertise: Induction of specialised scientific personnel for biologics evaluation.
    3. Global alignment: Synchronises approval timelines with international regulatory standards.

    What Is the Role of the National Biopharma Mission (NBM)?

    1. Budgetary linkage: Biopharma SHAKTI builds upon the National Biopharma Mission (NBM) launched in 2017.
    2. Mission objective: Transform India into a $100 billion biotech industry and capture 5% global share.
    3. Financial scale: ₹1,500 crore, co-funded by the World Bank.
    4. Implementing agency: Biotechnology Industry Research Assistance Council (BIRAC) under DBT.

    How Do Other Government Schemes Support Biopharma?

    1. BIRAC-led Innovation Support
      1. Infrastructure: 95 bio-incubation centres.
      2. Funding: BIG, SEED, LEAP funds for early-to-commercial stage innovation.
      3. Outcome: Nearly 1,000 innovators supported.
    2. Manufacturing Support Schemes
      1. PLI for Pharmaceuticals: Enhances domestic manufacturing capacity.
      2. Bulk Drug Parks Scheme: Reduces import dependence for APIs.
      3. SPI Scheme: Upgrades MSMEs to WHO-GMP standards.
    3. PRIP Scheme (2023)
      1. Focus: Biosimilars, complex generics, precision medicine, MedTech innovation.
    4. BioE3 Policy and Bio-RIDE Scheme
      1. Objective: Promote biomanufacturing, biofoundries, and bio-AI hubs.
      2. Sectors: Precision biotherapeutics, climate resilience, biobased chemicals.

    Conclusion

    Biopharma SHAKTI represents a consolidation of India’s decade-long investments in biotechnology, innovation, and pharmaceutical manufacturing. By prioritising biologics and biosimilars, the initiative addresses emerging disease patterns, strengthens regulatory credibility, and positions India for higher value capture in the global pharmaceutical economy.

    PYQ Relevance

    [UPSC 2021] What are the research and developmental achievements in applied biotechnology? How will these achievements help to uplift the poorer sections of society?

    Linkage: Biotechnology and applied life sciences are repeatedly tested areas in GS-III, especially in the context of public health, indigenous innovation, manufacturing, and affordability of medicines. Recent UPSC trends show a clear shift from static biotech definitions to policy-driven questions linking science, economy, and governance.

    Get an IAS/IPS ranker as your 1: 1 personal mentor

  • Electronic System Design and Manufacturing Sector – M-SIPS, National Policy on Electronics, etc.

    Rare Earth Corridors in Coastal States

    3 February 2026 | Prelims Only | Economics
    Mains Paper 3: Effects Of Liberalization On The Economy, Changes In Industrial Policy and their effects on Industrial Growth, Government Budgeting

    Why in the News?

    In Union Budget 2026-27, Finance Minister Nirmala Sitharaman announced the establishment of dedicated Rare Earth Corridors in the coastal states of Odisha, Kerala, Andhra Pradesh and Tamil Nadu to strengthen India’s critical minerals and advanced manufacturing ecosystem.

    What are Rare Earth Corridors?

    • State focused industrial corridors for Mining, Processing, Research andManufacturing of rare earth elements
    • Aim to integrate upstream mining with downstream value addition
    • Anchored in mineral rich coastal regions with Beach Sand Minerals

    Rare Earths in Indian Context

    • Principal source: Beach Sand Minerals (BSM)
    • Key mineral present: Monazite
      • A phosphate mineral
      • Contains Uranium and Thorium
    • Coastal states have rich deposits capable of producing rare earths like Neodymium and Praseodymium

    Link with Rare Earth Magnet Manufacturing Scheme

    • Corridors align with the scheme for Sintered Rare Earth Permanent Magnets
    • Financial outlay: Rs 7,280 crore
    • Target capacity:
      • 6,000 metric tonnes per annum
      • 5 beneficiaries selected via competitive bidding
      • Up to 1,200 MTPA per beneficiary
    • Incentives:
      • Rs 6,450 crore sales linked incentive over 5 years
      • Rs 750 crore capital subsidy

    Why Rare Earth Permanent Magnets Matter

    • Critical for: Electric vehicles, Wind turbines and renewable energy, Electronics and Aerospace and defence.
    • Global concentration: China controls over 90 percent of processing and magnet manufacturing
    • India imported over 53,000 metric tonnes of rare earth magnets in FY 2024-25
    • Domestic demand expected to double by 2030
    [2022] With reference to India, consider the following statements: 1. Monazite is a source of rare earths

    2. Monazite contains thorium

    3. Monazite occurs naturally in the entire Indian coastal sands in India

    4. In India, Government bodies only can process or export monazite

    Which of the statements given above are correct? 

    (a) 1, 2 and 3 only (b) 1, 2 and 4 only (c) 3 and 4 only (d) 1, 2, 3 and 4

    Get an IAS/IPS ranker as your 1: 1 personal mentor

  • Industrial Sector Updates – Industrial Policy, Ease of Doing Business, etc.

    India gives 20 year tax holiday to foreign firms using local data centres 

    3 February 2026 | Prelims Only | Economics
    Mains Paper 3: Indian Economy, Infrastructure: Energy, Ports, Roads, Airports, Railways Etc.

    Why in the News?

    In Union Budget 2026–27, Finance Minister Nirmala Sitharaman announced a 20 year tax holiday till 2047 for foreign companies that provide global cloud services using data centres located in India, to boost India’s position as a global data and digital services hub.

    What is the Announcement?

    • Foreign companies offering cloud and digital services globally
    • Using data centres physically located in India
    • Will not be taxed on global income arising from such services
    • Tax holiday applicable till the year 2047

    Key Benefits

    • Provides long term tax clarity and stability
    • Encourages hyperscalers to locate data storage and processing in India
    • Boosts employment, energy infrastructure and allied services
    • Strengthens India’s role in cloud computing, AI and digital trade

    Investments in Focus

    • Google plans 15 billion dollar investment in AI data centres in Andhra Pradesh
    • Microsoft and Amazon have invested billions in Indian data centres
    • Indian conglomerates like Reliance Industries and Adani Group are also major players

    Government View

    • IT Minister Ashwini Vaishnaw stated that data centres will become a major strength for India in providing digital services to the world
    [2018] With reference to India’s decision to levy an equalization tax of 6% on online advertisement services offered by non-resident entities, which of the following statements is/are correct? 1. It is introduced as a part of the Income Tax Act

    2. Non-resident entities that offer advertisement services in India can claim a tax credit in their home country under the “Double Taxation Avoidance Agreements”

    Select the correct answer using the code given below: 

    (a) 1 only (b) 2 only (c) Both 1 and 2 (d) Neither 1 nor 2

    Get an IAS/IPS ranker as your 1: 1 personal mentor

  • Health Sector – UHC, National Health Policy, Family Planning, Health Insurance, etc.

    Obesity in India and Budget 2026 Expectations  

    3 February 2026 | Prelims Only | Social Justice
    Mains Paper 2: Health & Education

    Why in the News?

    India has emerged as the third most obese country in the world after the US and China, according to the World Obesity Federation. The Economic Survey 2026 flagged obesity as a rising public health challenge across age groups, raising expectations from Union Budget 2026 to make healthy living affordable.

    Key Findings on Obesity in India

    • Global ranking: India is the third most obese country globally
    • Social spread:
      • 76 percent Indians report at least one obese person in their close social circle
      • 42 percent report four or more obese individuals around them
    • Associated diseases:
      • 56 percent obese individuals also suffer from lifestyle diseases like diabetes, hypertension, high cholesterol, fatty liver

    Causes of Rising Obesity

    • Sedentary lifestyle and lack of physical activity
    • High consumption of fatty and ultra processed foods
    • Urbanisation and screen based work culture
    • Poor dietary diversity and nutrition awareness

    Official Data  

    • National Family Health Survey 5:Overweight or obese adults:
      • Women: 24 percent
      • Men: 23 percent
      • Children under 5 with excess weight: Increased from 2.1 percent (2015–16) to 3.4 percent (2019–21)

    Health Implications

    • Higher risk of non communicable diseases like: Diabetes, Heart disease and Hypertension
    • Increased long term healthcare burden
    • Reduced productivity and quality of life

    Budget 2026 Expectations

    Citizens expect Budget 2026 to:

    • Reduce taxes on healthy food options
    • Improve affordability of fitness and preventive healthcare services
    • Discourage consumption of ultra processed foods through fiscal measures
    • Promote lifestyle based prevention over drug dependent solutions
    [2017] Which of the following are the objectives of ‘National Nutrition Mission’? 1. To create awareness relating to malnutrition among pregnant women and lactating mothers

    2. To reduce the incidence of anaemia among young children, adolescent girls and women

    3. To promote the consumption of millets, coarse cereals and unpolished rice

    4. To promote the consumption of poultry eggs

    Select the correct answer using the code given below: 

    (a) 1 and 2 only (b) 1, 2 and 3 only (c) 1, 2 and 4 only (d) 3 and 4 only

    Get an IAS/IPS ranker as your 1: 1 personal mentor

  • Pharma Sector – Drug Pricing, NPPA, FDC, Generics, etc.

    Biopharma Shakti Mission 

    3 February 2026 | Prelims Only | Economics
    Mains Paper 3: Government Budgeting, Indian Economy

    Why in the News?

    In Union Budget 2026, Finance Minister Nirmala Sitharaman announced the Biopharma Shakti Mission with an outlay of Rs 10,000 crore to make India a global hub for biologics and biosimilars.

    What is Biopharma Shakti Mission?

    A flagship mission to build a complete ecosystem for domestic manufacturing, clinical trials, and regulatory capacity in complex biological drugs.

    Key Features

    • Financial outlay: Rs 10,000 crore over 5 years
    • Focus areas: Biologics and biosimilars for NCDs like diabetes, cancer, autoimmune disorders
    • Infrastructure push:
      • 3 new NIPERs to be set up
      • 7 existing NIPERs to be upgraded
    • Clinical trials:
      • Network of 1,000 accredited clinical trial sites
      • Aims to capture a share of the global clinical trials market
    • Regulatory strengthening:
      • Capacity enhancement of Central Drugs Standard Control Organisation
      • Creation of a dedicated scientific review cadre
      • Alignment with global drug approval timelines

    Significance

    • Supports India’s transition from small molecule generics to next generation biologics
    • Addresses rising non communicable disease burden
    • Improves affordable access to advanced therapies
    • Boosts export competitiveness and global trust in Indian pharma

    Institutions in Focus

    • National Institute of Pharmaceutical Education and Research
    • CDSCO as the national drug regulator aligned to global standards
    [2025] With reference to monoclonal antibodies, consider the following: 1. They are man-made proteins

    2. They stimulate the patient’s immune system to fight the specific disease

    3. They are produced using animal cells only

    Which of the statements given above are correct? 

    (a) I and II only (b) II and III only (c) I and III only (d) All the three

    Get an IAS/IPS ranker as your 1: 1 personal mentor

  • Government Budgets

    [2nd February 2026] The Hindu OpED: Union Budget 2026-27: Pushing welfare towards the States

    2 February 2026 | op-ed snap | Economics
    Mains Paper 3: Government Budgeting

    PYQ Relevance

    [UPSC 2024] What changes has the Union Government recently introduced in the domain of Centre-State relations? Suggest measures to be adopted to build the trust between the Centre and the States and for strengthening federalism.

    Linkage: The question addresses evolving Centre-State relations, focusing on fiscal federalism, trust deficit, and the balance between autonomy and accountability in India’s federal structure. The article illustrates this shift through the Centre’s reduced welfare spending and increased reliance on States for social-sector delivery without proportional fiscal empowerment.

    Mentor’s Comment

    There is a clear shift in India’s welfare system. Budget 2026-27 shows that States are being made more responsible for welfare spending, while the Union government continues to set rules and standards. It raises concerns about reduced social-sector spending, limited fiscal capacity of States, and unequal governance. The issue is important for GS-II and GS-III as it links fiscal federalism, social justice, public finance, and welfare delivery.

    Why in the News?

    Budget 2026-27 reflects an unusual pattern: despite the absence of new flagship schemes, allocations for core welfare sectors remain low and, in several cases, under-spent. For the first time in recent years, there is a clear shift of welfare burden towards States, while the Centre retains control through legislation and standards. This contrast between decentralised spending responsibility and centralised policy authority marks a significant departure from earlier centrally driven welfare expansion.

    Has social-sector spending lost priority in Budget 2026-27?

    1. Unchanged Social Sector Share: Maintains the same proportion of total expenditure as previous years, despite rising welfare needs.
    2. Health and Education Allocation: Registers a marginal increase of 4% in 2026-27 BE, which translates to only 2.3% growth in real terms after inflation.
    3. Below-Minimum Requirement: Requires at least 7% annual growth to sustain existing service levels, indicating effective stagnation.
    4. Under-Spending Trend: Budget Estimates (BE) consistently exceed Revised Estimates (RE), showing that even allocated funds remain unspent.

    Which welfare schemes are witnessing the sharpest decline?

    1. Urban Livelihoods (DAY-NULM): Allocation reduced by 41%, reflecting declining focus on urban poor employment.
    2. Rural Development: Faces a 20% reduction, weakening livelihood and asset-creation programmes.
    3. North-East Development: Allocation falls by 24%, affecting regional equity.
    4. Social Welfare Programmes: Experience broad-based contraction across sectors.
    5. Jal Jeevan Mission: Allocation drops from ₹67,000 crore in 2025-26 BE to ₹35,000 crore in 2026-27 BE.
    6. PMAY-Urban: Reduced from ₹54,832 crore (RE) to ₹45,482 crore (BE).
    7. PMAY-Rural: Declines from ₹79,794 crore to ₹54,832 crore.
    8. Education Schemes (CSS): Fall from ₹5,41,850 crore in 2025-26 BE to ₹4,20,078 crore in 2026-27 BE.
    9. Health Schemes: Reduced from ₹5,48,798 crore to ₹4,57,498 crore.

    Is the emphasis on capital expenditure displacing welfare priorities?

    1. Capex Bias: Prioritises infrastructure spending over social consumption.
    2. Demand Constraint: Weak purchasing power limits the multiplier effect of capex.
    3. Employment Impact: Fails to generate sufficient jobs, particularly for educated youth.
    4. Private Investment Response: Remains muted, questioning capex-led growth assumptions.
    5. Economic Slackness: Over ₹12 lakh crore remains unspent or underutilised in the economy.

    How is the welfare burden shifting towards the States?

    1. Budget Consolidation: Budget 2026-27 formalises the transfer of welfare responsibility to States.
    2. Centre’s Role: Continues norm-setting through legislation, while reducing direct spending.
    3. Increased State Share: States now bear a larger proportion of social-sector expenditure.
    4. Revenue Constraint: States receive only around 34% of net tax revenues.
    5. Finance Commission Signal: Recommends reduced cesses and surcharges, yet these continue.
    6. Vertical Imbalance: Centre’s tax dominance contrasts with States’ spending obligations.

    Do States have the fiscal capacity to absorb this shift?

    1. Limited Revenue Autonomy: States remain dependent on Central transfers.
    2. Declining Share: States’ share in Central taxes has fallen from ₹1,32,767 crore (2025-26 BE) to ₹1,29,397 crore (2026-27 BE).
    3. Expenditure Pressure: Welfare responsibilities expand without commensurate fiscal space.
    4. Governance Risk: Uneven capacity among States risks regional disparities in welfare outcomes.

    What governance challenges persist in welfare delivery?

    1. Demand-Side Weakness: Poor purchasing power suppresses welfare impact.
    2. Supply-Side Gaps: Inadequate public provisioning persists.
    3. Human Capital Stress: Education and health underinvestment affects long-term productivity.
    4. Structural Unemployment: Skills mismatch remains unresolved.
    5. Income Stagnation: Low wages constrain inclusive growth.

    Conclusion

    As the Centre withdraws from direct welfare spending while retaining legislative authority, States are left managing rising social obligations with constrained fiscal capacity. Without correcting this imbalance, welfare delivery risks becoming uneven, under-funded, and ineffective.

    Get an IAS/IPS ranker as your 1: 1 personal mentor

  • Higher Education – RUSA, NIRF, HEFA, etc.

    Why have the new UGC regulations been stayed

    2 February 2026 | Explained | Social Justice
    Mains Paper 2: Health & Education

    Why in the News?

    On January 29, the Supreme Court stayed the University Grants Commission (UGC) Equity Regulations, 2026 due to unclear provisions on caste-based discrimination. The regulations had been notified only weeks earlier to replace the 2012 framework that had guided campuses for over a decade. The stay is unusual, as equity regulations are rarely halted at the initial stage, and it reflects judicial concern that protections may have been weakened. Protests by student groups across the country highlight the continued seriousness of caste discrimination in higher education.

    What Are the UGC Equity Regulations, 2026?

    1. Regulatory Framework: The University Grants Commission (Promotion of Equity in Higher Education Institutions) Regulations, 2026 notified in January 2026.
    2. Definition of Caste-Based Discrimination: Limits caste discrimination to actions “only on the basis of caste or tribe” against SC, ST, and OBC students.
    3. Scope of Discrimination: Defines discrimination as unfair, differential, or biased treatment, explicit or implicit, on grounds including religion, race, caste, gender, place of birth, or disability.
    4. Institutional Mechanism: Establishes Equal Opportunity Centres, Equity Committees, and Equity Squads in institutions and departments.
    5. Accountability Provision: Introduces penalties for institutions violating equity norms.

    Why Were the New Regulations Introduced?

    1. Judicial Origin: Emerged from Supreme Court hearings following the suicides of Rohith Vemula (2016) and Payal Tadvi (2019).
    2. Petitioner’s Argument: Contended that the 2012 UGC regulations failed to address “rampant caste discrimination” in higher education.
    3. Expert Committee: UGC constituted a committee under Prof. Shailesh N. Zala to revise the 2012 framework.
    4. Regulatory Outcome: Committee submitted revised equity regulations, which were notified as the 2026 regulations.

    How Did the 2026 Regulations Depart from the 2012 Framework?

    1. Definition Gap: 2012 regulations did not separately define caste-based discrimination; the 2026 rules narrowly define it.
    2. Grievance Redressal: 2012 regulations mandated grievance redressal mechanisms including SC/ST Cells and anti-discrimination officers.
    3. Complaint Coverage: 2012 framework explicitly covered denial of admissions, social interactions, and campus life aspects.
    4. Missing Provisions: 2026 regulations omit several specific safeguards present in the 2012 regulations.
    5. Continuity Clause: 2012 regulations provided consequences for non-implementation; 2026 rules dilute enforcement clarity.

    Why Were the Regulations Said to Be Biased?

    1. General Category Concern: Protesters argued regulations discriminate against general and upper-caste students.
    2. False Complaints Clause: Provision for punishment of “false complaints” seen as discouraging genuine reporting.
    3. Presumption Issue: Upper-caste students argued regulations presupposed them as perpetrators.
    4. Ambiguity Critique: Supreme Court noted vagueness in defining caste-based discrimination.
    5. Institutional Risk: Fear of misuse of ambiguous provisions against faculty and students.

    What Did the Supreme Court Hold?

    1. Judicial Finding: Found prima facie vagueness in the regulations.
    2. Interim Relief: Stayed implementation of the 2026 regulations.
    3. Status Quo Direction: Allowed UGC to revert to the 2012 regulations during pendency.
    4. Hearing Timeline: Scheduled detailed hearing after petitions are heard fully.
    5. Judicial Signal: Emphasised need for clarity and enforceability in equity regulations.

    Conclusion

    The stay on the UGC Equity Regulations, 2026 underscores the constitutional sensitivity of caste-based discrimination in higher education. By halting a framework perceived to dilute existing safeguards, the Supreme Court reaffirmed that regulatory reform must strengthen, not weaken, substantive equality. The episode highlights the centrality of precise definitions, enforceable grievance mechanisms, and institutional accountability in addressing social discrimination on campuses.

    PYQ Relevance

    [UPSC 2023] Though the Human Rights Commissions have contributed immensely to the protection of human rights in India, yet they have failed to assert themselves against the mighty and powerful. Analyzing their structural and practical limitations, suggest remedial measures.

    Linkage: The Supreme Court’s stay on the UGC Equity Regulations, 2026 mirrors concerns raised in GS-II 2023 regarding the inability of statutory bodies to effectively protect vulnerable groups due to structural and design weaknesses. In both cases, diluted mandates and weak enforcement necessitated judicial intervention to uphold substantive equality.

    Get an IAS/IPS ranker as your 1: 1 personal mentor

  • Electric and Hybrid Cars – FAME, National Electric Mobility Mission, etc.

    What’s ailing India’s battery scheme for EVs

    2 February 2026 | Explained | Economics
    Mains Paper 3: Indigenization Of Technology, Infrastructure: Energy, Ports, Roads, Airports, Railways Etc.

    Why in the News?

    The ₹18,100 crore PLI Scheme for Advanced Chemistry Cell (ACC) Battery Storage, launched to create 50 GWh of domestic battery manufacturing capacity by 2025, has achieved only 1.4 GWh of installed capacity even after multiple bidding rounds. Despite awarding 20 GWh of capacity and disbursing commitments to three beneficiaries, no incentive funds have been released due to missed milestones. The scheme has attracted only 25.58% of the targeted investment, far below expectations. This represents a sharp contrast with the scheme’s original promise of rapidly catalysing India’s EV battery ecosystem and exposes structural weaknesses in mineral supply, technology readiness, and industrial execution.

    What are Advanced Chemistry Cells (ACCs)?

    1. Energy storage systems: Enable storage of electrical energy and conversion back to electricity as required.
    2. Lithium-ion dominance: Represent the most widely used battery chemistry globally, particularly in EVs and electronics.
    3. Technology-agnostic design: Allows multiple chemistries, including lithium manganese cobalt, lithium iron phosphate, and sodium-ion batteries.

    What was the intent behind the ACC PLI scheme?

    1. Manufacturing ecosystem creation: Seeks establishment of large-scale domestic battery manufacturing capacity.
    2. Import substitution: Reduces reliance on Chinese battery imports and supply chains.
    3. Strategic value chain integration: Requires complementary policies for mineral refining and component manufacturing.

    How was the scheme designed to function?

    1. Capacity-linked incentives: Rewards firms based on committed and operational manufacturing capacity.
    2. Minimum scale requirement: Mandates at least 5 GWh per participant to ensure economies of scale.
    3. Investment threshold: Requires ₹225 crore per GWh of committed capacity.
    4. Performance-linked payouts: Allows incentives up to ₹2,000 per kWh sold.
    5. Domestic Value Addition (DVA): Mandates 25% DVA within two years and 60% by the fifth year.

    Who were selected as beneficiaries under the scheme?

    1. Ola Electric: Awarded 20 GWh capacity initially; operationalised only 1.4 GWh by October 2025.
    2. Reliance New Energy: Allocated 5 GWh in the first round and an additional 10 GWh in the second round.
    3. Rajesh Exports: Allocated 5 GWh capacity.

    What has been the actual performance so far?

    1. Capacity shortfall: Only 1.4 GWh operational against a target of 50 GWh by 2025.
    2. Investment gap: Scheme generated only ₹1,118 crore, compared to an expected ₹4,360 crore.
    3. Zero disbursement: No incentive payouts released despite elapsed timelines.
    4. Concentration risk: Entire operational capacity limited to a single beneficiary.

    Why has the ACC PLI scheme underperformed?

    1. Unrealistic gestation period: Two-year commissioning timeline unsuitable for complex battery manufacturing plants.
    2. Mineral processing gaps: India lacks domestic facilities for lithium, nickel, and cobalt refining.
    3. Subsidy-centric design: Emphasises financial incentives without adequate ecosystem readiness.
    4. Execution capability mismatch: New entrants lack manufacturing experience compared to established global players.
    5. Supply chain dependence: Continued reliance on China for raw materials, equipment, and technical approvals.
    6. Regulatory delays: Slow clearance of Chinese technical specialists and technology transfer processes.
    7. Skilled labour deficit: Insufficient trained workforce for precision battery cell manufacturing.

    What does the article recommend going forward?

    1. Faster regulatory approvals: Accelerates visas and clearances for foreign technical expertise.
    2. Penalty relaxation: Extends commissioning deadlines by at least one year to reflect ground realities.
    3. Value chain deepening: Requires targeted schemes for mineral refining and component manufacturing.
    4. Technology and R&D focus: Prioritises domestic innovation over assembly-led expansion.
    5. Human capital development: Builds specialised skill pipelines for battery manufacturing.

    Conclusion

    The ACC PLI scheme reveals that fiscal incentives alone cannot substitute for ecosystem readiness. Manufacturing scale, mineral security, skilled labour, and technological capability must evolve simultaneously. Without structural correction, India’s battery ambitions risk remaining aspirational rather than transformative.

    PYQ Relevance

    [UPSC 2023] The adoption of electric vehicles is rapidly growing worldwide. How do electric vehicles contribute to reducing carbon emissions and what are the key benefits they offer compared to traditional combustion engine vehicles?

    Linkage: Electric vehicles reduce carbon emissions only when supported by clean electricity and efficient energy storage; weak domestic battery manufacturing limits these climate gains. Without strong domestic battery manufacturing, EV adoption may remain limited to vehicle sales rather than real decarbonisation.

    Get an IAS/IPS ranker as your 1: 1 personal mentor

  • Government Budgets

    Union Budget 2026–27 

    2 February 2026 | Prelims Only | Economics
    Mains Paper 3: Government Budgeting, Indian Economy

    Why in the News?

    The Union Budget of India for 2026–27 was presented on 1 February 2026 by Nirmala Sitharaman, focusing on Yuva Shakti, inclusive growth and long term economic resilience.

    Budget Theme and Vision

    • Yuva Shakti driven Budget with focus on poor, underprivileged and disadvantaged
    • First Budget prepared in Kartavya Bhawan
    • Anchored on 3 Kartavya
      • Accelerate and sustain economic growth
      • Fulfil aspirations and build capacity
      • Sabka Sath Sabka Vikas towards Viksit Bharat

    Major Economic and Fiscal Announcements

    • Public Capex increased to ₹12.2 lakh crore in FY 2026–27
    • Fiscal deficit targeted at 4.3 percent of GDP
    • Debt to GDP ratio projected at 55.6 percent
    • Net market borrowing at ₹11.7 lakh crore

    Taxation Reforms

    Direct Taxes

    • New Income Tax Act, 2025 effective from April 2026
    • Simplified income tax rules and forms
    • TCS on overseas tour packages reduced to 2 percent
    • STT on futures increased to 0.05 percent
    • MAT rate reduced to 14 percent and made final tax
    • Multiplicity of penalty and prosecution proceedings reduced

    Support to IT and Global Investment

    • Single category of IT Services with safe harbour margin of 15.5 percent
    • Safe harbour threshold raised to ₹2,000 crore
    • Foreign cloud service providers to get tax holiday till 2047
    • MAT exemption to all non residents paying tax on presumptive basis

    Indirect Taxes and Customs

    • Basic customs duty exemption
      • Capital goods for lithium ion batteries
      • Critical minerals processing equipment
      • 17 drugs and medicines
    • Tariff on personal imports reduced from 20 percent to 10 percent
    • Customs warehousing shifted to operator centric digital system
    • Single digital window for cargo clearance by end of financial year

    Sector Specific Highlights

    Manufacturing and MSMEs

    • ₹10,000 crore SME [Small and Medium Enterprises] Growth Fund
    • Scaling manufacturing in 7 strategic sectors
    • Textile sector integrated programme including Samarth 2.0

    Infrastructure and Transport

    • Seven high speed rail corridors as growth connectors
    • New Dedicated Freight Corridors
    • Operationalisation of 20 National Waterways

    Health, Education and Social Sector

    • Biopharma SHAKTI with outlay of ₹10,000 crore
    • One girls hostel in every district for STEM institutions
    • Medical tourism hubs in partnership with private sector
    • NIMHANS 2 and mental health institutes upgrade

    Technology and AI

    • Bharat VISTAAR multilingual AI tool for agriculture
    • AVGC content creator labs in 15,000 schools and 500 colleges

    Sports and Tourism

    • Launch of Khelo India Mission
    • Upskilling 10,000 tourist guides
    • Buddhist Circuit development in North East
    [2024] With reference to Union Budget, consider the following statements: 

    1. The Union Finance Minister on behalf of the Prime Minister lays the Annual Financial Statement before both the Houses of Parliament

    2. At the Union level, no demand for a grant can be made except on the recommendation of the President of India

    Which of the statements given above is/are correct? 

    (a) 1 only (b) 2 only (c) Both 1 and 2 (d) Neither 1 nor 2

    Get an IAS/IPS ranker as your 1: 1 personal mentor

Join the Community

Join us across Social Media platforms.